Titan Pharmaceuticals Announces Fourth Quarter and Year End 2013 Financial …
Titan Pharmaceuticals Announces Fourth Quarter and Year End 2013 Financial …
Probuphine is an investigational subdermal implant designed to deliver continuous, around-the-clock blood levels of buprenorphine for six months following a single treatment, and to simplify patient compliance and retention. … Titan has been issued …
Read more on SYS-CON Media (press release)